WebMeta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study) Breast Cancer . 2024 Sep;28(5):1023-1037. doi: 10.1007/s12282-021-01238-9. Web23 set 2024 · The authors would like to thank the patients who participated in the JBCRG-17 study and their families and the investigators and research coordinators at the …
Clinical Trials - 一般社団法人JBCRG(Japan Breast Cancer ...
Web23 apr 2024 · With this background, to evaluate the clinical usefulness of eribulin in comparison with TPC as first- or second-line treatment for recurrent HER2-negative breast cancer in patients who had previously received AT containing regimens and to determine whether to proceed to a phase III study, we conducted a phase II study (JBCRG-19) to … Web23 set 2024 · The authors would like to thank the patients who participated in the JBCRG-17 study and their families and the investigators and research coordinators at the participating institutions. The authors would also like to thank Nobuko Aoki, Michiro Soma, and their colleagues from the Japan Breast Cancer Research Group (JBCRG) administrative … natural resources wales head office address
Our Vision - 一般社団法人JBCRG(Japan Breast Cancer …
Web27 apr 2024 · Circulating tumor cells (CTCs) are cancer cells that are detected in the patient’s blood. The development of robust and clinical study-friendly techniques has led to thorough investigation of CTCs as biomarkers in stageIV breast cancer, where CTCs can frequently be detected. About 70% of metastatic breast cancer patients exhibit no less … WebPurpose: To investigate clinical usefulness of eribulin-based neoadjuvant chemotherapy in triple-negative breast cancer (TNBC) patients. Methods: Patients in group A (aged < 65 years with homologous recombination deficiency, HRD, score ≥ 42, or those at any age with germline BRCA mutation, gBRCAm) were randomized to 4 cycles of paclitaxel plus … marilyn monroe haunted hotel room rate